학술논문

Efficacy of the nanoparticle–drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I–IIa clinical trial
Document Type
Article
Source
In Annals of Oncology August 2016 27(8):1579-1585
Subject
Language
ISSN
0923-7534